Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, Genova, Italy.
1] Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy [2] Behavioural Neuroscience Section, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy.
Neuropsychopharmacology. 2014 Apr;39(5):1102-14. doi: 10.1038/npp.2013.310. Epub 2013 Nov 4.
Intranasal administration of oxytocin (OXT) might be a promising new adjunctive therapy for mental disorders characterized by social behavioral alterations such as autism and schizophrenia. Despite promising initial studies in humans, it is not yet clear the specificity of the behavioral effects induced by chronic intranasal OXT and if chronic intranasal OXT could have different effects compared with single administration. This is critical for the aforementioned chronic mental disorders that might potentially involve life-long treatments. As a first step to address these issues, here we report that chronic intranasal OXT treatment in wild-type C57BL/6J adult mice produced a selective reduction of social behaviors concomitant to a reduction of the OXT receptors throughout the brain. Conversely, acute intranasal OXT treatment produced partial increases in social behaviors towards opposite-sex novel-stimulus female mice, while on the other hand, it decreased social exploration of same-sex novel stimulus male mice, without affecting social behavior towards familiar stimulus male mice. Finally, prolonged exposure to intranasal OXT treatments did not alter, in wild-type animals, parameters of general health such as body weight, locomotor activity, olfactory and auditory functions, nor parameters of memory and sensorimotor gating abilities. These results indicate that a prolonged over-stimulation of a 'healthy' oxytocinergic brain system, with no inherent deficits in social interaction and normal endogenous levels of OXT, results in specific detrimental effects in social behaviors.
鼻腔内给予催产素(OXT)可能是一种有前途的新辅助治疗方法,可用于治疗以社交行为改变为特征的精神障碍,如自闭症和精神分裂症。尽管在人类中进行了初步的有希望的研究,但目前尚不清楚慢性鼻腔内给予 OXT 诱导的行为效应的特异性,以及慢性鼻腔内给予 OXT 是否会与单次给药产生不同的效果。对于上述慢性精神障碍,这一点至关重要,因为这些疾病可能需要终身治疗。为了解决这些问题,我们首先报告,在野生型 C57BL/6J 成年小鼠中进行慢性鼻腔内 OXT 治疗会导致整个大脑中的 OXT 受体减少,同时选择性地降低社交行为。相反,急性鼻腔内给予 OXT 治疗会使雄性小鼠对异性新刺激的雌性小鼠的社交行为部分增加,而另一方面,它会减少雄性小鼠对同性新刺激的社交探索,而不影响对熟悉刺激的雄性小鼠的社交行为。最后,在野生型动物中,长时间暴露于鼻腔内 OXT 治疗不会改变一般健康参数,如体重、运动活动、嗅觉和听觉功能,也不会改变记忆和感觉运动门控能力的参数。这些结果表明,对“健康”的催产素能脑系统进行长时间过度刺激,在没有社交互动固有缺陷和正常内源性 OXT 水平的情况下,会导致社交行为产生特定的有害影响。